Regeneron Pharmaceuticals, Inc. (REGN): A Bull Case Theory
We came across a bullish thesis on Regeneron Pharmaceuticals, Inc. on Notes From The Beauty Contest’s Substack by Crashkolnikov. In this article, we will summarize the bulls’ thesis on REGN.
Regeneron Pharmaceuticals Inc. (REGN)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period: Filing is Ongoing
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Bronte Capital John Hempton | 176,768 | $136,441,916 | -2% | 13.61% |
| 2. | 59,300 | $45,771,891 | 4.57% | ||
| 3. | Lee Munder Capital Group Lee Munder | 39,821 | $30,736,635 | +10% | 1.76% |
| 4. | Bailard Inc Thomas Bailard | 3,374 | $2,604,289 | -4% | 0.06% |
| 5. | GAMCO Investors Mario Gabelli | 649 | $500,944 | +1% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $487.01 | 2,557 | $1,245,286.62 | 23,880,537 | 2017-08-25 | Filing | |
| $485.99 | 2,681 | $1,302,949.65 | 23,877,980 | 2017-08-25 | Filing | |
| $485.28 | 5,723 | $2,777,256.30 | 23,875,299 | 2017-08-25 | Filing | |
| $484.21 | 2,000 | $968,420.00 | 23,869,576 | 2017-08-25 | Filing | |
| $482.87 | 4,485 | $2,165,687.20 | 23,867,576 | 2017-08-25 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $800.00 | 1,500 | $1,200,000.00 | 1,703 | 2026-01-07 | Filing | |
| $750.00 | 760 | $570,000.00 | 1,548 | 2025-11-20 | Filing | |
| $651.43 | 431 | $280,766.33 | 4,233 | 2025-11-07 | Filing | |
| $657.29 | 388 | $255,028.52 | 2,352 | 2025-10-29 | Filing | |
| $656.50 | 712 | $467,428.00 | 2,740 | 2025-10-29 | Filing |
Institutional Investors' Holdings
Filing Period: Filing is Ongoing
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 9,075,153 | $7,004,838,346 | 0.1% | |
| 2. | 367,870 | $284,716,336 | 0.28% | |
| 3. | 285,031 | $220,006,878 | 0.13% | |
| 4. | 271,158 | $209,298,725 | 0.03% | |
| 5. | 261,850 | $202,114,158 | 0.29% |
News See All
Regeneron (REGN) Draws Higher Target From TD Cowen
During the Q4 2025 earnings call, CEO Leonard Schleifer said Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) delivered steady revenue growth. Fourth-quarter sales rose 3% from a year earlier.
Regeneron Pharmaceuticals, Inc. (REGN) Posts Q4 Earnings Beat, EPS Shines
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) is among the most profitable healthcare stocks to buy. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q4 2025 Earnings Call Transcript
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Q4 2025 Earnings Call Transcript January 30, 2026Regeneron Pharmaceuticals, Inc. beats earnings expectations.
13 Companies that Just Started Paying Dividends
The latest figures from S&P Dow Jones Indices show dividend growth didn’t stall in 2025, but it clearly slowed.
10 Most Profitable Healthcare Stocks to Buy
By far, the healthcare sector remains among the most resilient and profitable in global equity markets.
Evercore ISI Highlights Dupixent and Eylea HD as Key Growth Drivers For Regeneron Pharmaceuticals, Inc. (REGN)
TheFly reported on January 22 that Evercore ISI increased its price target for REGN to $875 from $750 and maintained an Outperform rating on the stock.
20 Most Profitable Stocks of the Last 20 Years
Investing in the stock market could be both advantageous and difficult, especially for those seeking companies with robust long-term development and profitability.
Regeneron (REGN) Posted Solid Quarterly Results, Eyes 2026 Pipeline Catalysts
Chautauqua Capital Management, a division of Baird Asset Management, is a boutique investment firm that released its fourth-quarter 2025 investor letter for the “Baird Chautauqua International and ...
Should You Be Excited for Regeneron (REGN)?
Longleaf Partners, managed by Southeastern Asset Management, released its fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here.
Hedge Fund Resource Center Billionaire Hedge Funds
